Governor Mauricio Vila Dosal leads a work mission to the city of Washington DC, United States, where he continues to promote Yucatán to investors from this country and technology companies, as well as the tourism sector. As part of his first day in the US capital, he met with representatives of important companies and organizations
NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations highlighting data from the ULTIMATE I & II Phase 3
TG Therapeutics Announces Schedule Of Data Presentations For BRIUMVI® (Ublituximab) In Multiple Sclerosis At The Americas Committee For Treatment And menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
20.02.2024 - NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) - TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations highlighting data from the ULTIMATE I & II Phase 3 trials and the ENHANCE Phase 3b trial evaluating . Seite 1
/PRNewswire/ FibroBiologics (Nasdaq: FBLG) ("FibroBiologics") is a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on.